Prognostic role of controlling nutritional status score in hematological malignancies
Year: 2022
Type: review
Abstract: BACKGROUND: Controlling nutritional status (CONUT) score, based on three indexes including serum albumin (ALB), total cholesterol (CHO), and absolute lymphocyte count (ALC), has been closely associated with the prognosis of cancer patients. Multiple studies revealed the significance of CONUT score in hematological malignancies, including diffuse large B-cell lymphoma (DLBCL), peripheral T-cell lymphoma (PTCL), multiple myeloma (MM), and leukemia. OBJECTIVE: This review aimed to explore the prognostic role of CONUT score in hematological malignancies. METHODS: We conducted this review through Pubmed to summarize the published studies on the CONUT score in hematological malignancies, using the terms: Controlling nutritional status, CONUT score, hematological malignancy, lymphoma, multiple myeloma, and leukemia. RESULT: CONUT score can reflect not only the nutritional status but also the inflammatory status of patients with hematological malignancies. It can assist in predicting the survival of patients with DLBCL, PTCL, MM, adult T-cell leukemia (ATL), myelodysplastic syndrome (MDS), and acute myeloid leukemia with myelodysplasia related changes (AML-MRC). CONCLUSION: CONUT score plays an important role in predicting the prognosis of patients with hematological malignancies.
Source: Hematology
Authors: Yijing Zhang, Qiuni Chen, Chuanyang Lu, Liang Yu
Institutions: Huaian First People’s Hospital, Nanjing Medical University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: Controlling Nutritional Status score, controlling nutritional status, hematologic malignancies, prognostic factors, nutritional status, serum albumin, total cholesterol, absolute lymphocyte count, diffuse large B-cell lymphoma, peripheral T-cell lymphoma, multiple myeloma, leukemia, adult T-cell leukemia/lymphoma, myelodysplastic syndrome, acute myeloid leukemia, survival prediction, inflammation
Open Access status: gold
Estimated APC paid: $2,557
Funder: FP7 People: Marie-Curie Actions
OpenAlex ID: W4281691069
